MIST 8-K: SEC filing

Milestone Pharmaceuticals Inc.

Filed with the SEC on · accession 0001104659-26-126519

MIST filed a 8-K (current report) with the SEC on Nov 13, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Milestone Pharmaceuticals Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2026, along with other business highlights.

Key details

RegistrantMilestone Pharmaceuticals Inc.
General counsel and chief compliance officerDavid Sandoval

✦ Ask GOAX AI about this filing — what it means for MIST, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MIST?

Click here

Frequently asked questions

What did MIST file with the SEC on Nov 13, 2026?

MIST filed a 8-K (SEC filing). Milestone Pharmaceuticals Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2026, along with other business highlights.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other MIST SEC filings

Get alerts when MIST files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days